These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34793985)

  • 1. Implementation of platform trials in the COVID-19 pandemic: A rapid review.
    Vanderbeek AM; Bliss JM; Yin Z; Yap C
    Contemp Clin Trials; 2022 Jan; 112():106625. PubMed ID: 34793985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.
    Manoharan L; Olliaro P; Horby PW; Watson CH
    Trials; 2021 May; 22(1):370. PubMed ID: 34051840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platform trials to evaluate the benefit-risk of COVID-19 therapeutics: Successes, learnings, and recommendations for future pandemics.
    Buenconsejo J; Liao R; Lin J; Singh P; Cooner F; Ghosh S; Gamalo M; Russek-Cohen E; Zariffa N
    Contemp Clin Trials; 2023 Sep; 132():107292. PubMed ID: 37454729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology and design of platform trials: a meta-epidemiological study.
    Pitre T; Cheng S; Cusano E; Khan N; Mikhail D; Leung G; Vernooij RWM; Yarnell CJ; Goligher E; Murthy S; Heath A; Mah J; Rochwerg B; Zeraatkar D
    J Clin Epidemiol; 2023 May; 157():1-12. PubMed ID: 36893990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 on otolaryngology research: a cross-sectional analysis of discontinued trials.
    Rucker BM; Sajjadi NB; Brame LS; Vassar M; Hartwell ML
    J Osteopath Med; 2022 Apr; 122(8):393-399. PubMed ID: 35363445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
    Huang DT; McCreary EK; Bariola JR; Wadas RJ; Kip KE; Marroquin OC; Koscumb S; Collins K; Shovel JA; Schmidhofer M; Wisniewski MK; Sullivan C; Yealy DM; Axe M; Nace DA; Haidar G; Khadem T; Linstrum K; Snyder GM; Seymour CW; Montgomery SK; McVerry BJ; Berry L; Berry S; Meyers R; Weissman A; Peck-Palmer OM; Wells A; Bart R; Albin DL; Minnier T; Angus DC
    Trials; 2021 May; 22(1):363. PubMed ID: 34034784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings.
    Noor NM; Pett SL; Esmail H; Crook AM; Vale CL; Sydes MR; Parmar MKB
    F1000Res; 2020; 9():1109. PubMed ID: 33149899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape.
    Hedlin H; Garcia A; Weng Y; He Z; Sundaram V; Bunning B; Balasubramanian V; Cunanan K; Kapphahn K; Gummidipundi S; Purington N; Boulos M; Desai M
    Clin Trials; 2021 Jun; 18(3):324-334. PubMed ID: 33535821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
    Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
    Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
    Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
    BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial research agenda on COVID-19 - the first two years in Germany and beyond.
    Hirt J; Janiaud P; Hemkens LG
    Z Evid Fortbild Qual Gesundhwes; 2022 Nov; 174():32-42. PubMed ID: 36180342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platform trials.
    Roustit M; Demarcq O; Laporte S; Barthélémy P; Chassany O; Cucherat M; Demotes J; Diebolt V; Espérou H; Fouret C; Galaup A; Gambotti L; Gourio C; Guérin A; Labruyère C; Paoletti X; Porcher R; Simon T; Varoqueaux N
    Therapie; 2023; 78(1):29-38. PubMed ID: 36529559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence-FAST Evidence.
    Liao G; Zheng K; Lalu MM; Fergusson DA; Allan DS
    Transfus Med Rev; 2020 Jul; 34(3):165-171. PubMed ID: 32684483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, Progression, and Output of Randomized Platform Trials: A Systematic Review.
    Griessbach A; Schönenberger CM; Taji Heravi A; Gloy V; Agarwal A; Hallenberger TJ; Schandelmaier S; Janiaud P; Amstutz A; Covino M; Mall D; Speich B; Briel M
    JAMA Netw Open; 2024 Mar; 7(3):e243109. PubMed ID: 38506807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
    Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.